Intermolecular interactions between members of both similar and divergent G protein-coupled receptor subfamilies have been shown in various experimental systems. Here, we demonstrate heterodimerization of predominant b-adrenergic receptor (bAR) subtypes expressed in the heart, b1AR and b2AR, and its physiological relevance. In intact adult mouse cardiac myocytes lacking native b1AR and b2AR, co-expression of both bAR subtypes led to receptor heterodimerization, as evidenced by their co-immunoprecipitation, co-localization at optical resolution, and markedly increased binding affinity for subtype-selective ligands. As a result, the dose-response curve of myocyte contraction to bAR agonist stimulation with isoproterenol (ISO) was shifted leftward by ~1.5 orders of magnitude, and the response of cellular cAMP formation to ISO was enhanced concomitantly, indicating that intermolecular interactions of bAR subtypes resulted in sensitization of these receptors in response to agonist stimulation. In contrast, the presence of b1AR greatly suppressed ligand-independent spontaneous activity of co-existing b2ARs. Thus, heterodimerization of b1AR and b2AR in intact cardiac myocytes creates a novel population of bARs with distinct functional and pharmacological properties, resulting in enhanced signaling efficiency in response to agonist stimulation while silencing ligand-independent receptor activation, thereby optimizing b-adrenergic modulation of cardiac contractility.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Intramural Research (Z01)
Project #
1Z01AG000858-02
Application #
7327060
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
2
Fiscal Year
2006
Total Cost
Indirect Cost
Name
Aging
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Xiao, Rui-Ping; Zhu, Weizhong; Zheng, Ming et al. (2006) Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 27:330-7
Zheng, Ming; Zhu, Weizhong; Han, Qide et al. (2005) Emerging concepts and therapeutic implications of beta-adrenergic receptor subtype signaling. Pharmacol Ther 108:257-68
Zhu, Wei-Zhong; Chakir, Khalid; Zhang, Shengjun et al. (2005) Heterodimerization of beta1- and beta2-adrenergic receptor subtypes optimizes beta-adrenergic modulation of cardiac contractility. Circ Res 97:244-51
Zhu, Weizhong; Zeng, Xiaokun; Zheng, Ming et al. (2005) The enigma of beta2-adrenergic receptor Gi signaling in the heart: the good, the bad, and the ugly. Circ Res 97:507-9
Xiao, Rui-Ping; Zhu, Weizhong; Zheng, Ming et al. (2004) Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25:358-65
Xiao, R-P; Balke, C W (2004) Na+/Ca2+ exchange linking beta2-adrenergic G(i) signaling to heart failure: associated defect of adrenergic contractile support. J Mol Cell Cardiol 36:7-11
Pepe, Salvatore; van den Brink, Olivier W V; Lakatta, Edward G et al. (2004) Cross-talk of opioid peptide receptor and beta-adrenergic receptor signalling in the heart. Cardiovasc Res 63:414-22